Fraud by healthcare professionals and patients is a huge weight on NHS Fraudulent practices by healthcare professionals and patients are a huge financial burden on the NHS, according to a report by a major accountancy firm.…
FDA gives the green light for cariprazine to treat schizophrenia or bipolar disorder The US Food and Drug Administration has approved the atypical antipsychotic cariprazine (Vraylar) to treat adults with schizophrenia or bipolar disorder.…
Antioxidant shows promise in preventing hearing loss caused by aminoglycoside antibiotics Researchers are calling for a clinical trial to determine the protective effects of N-acetylcysteine in reducing the risk of deafness in patients taking aminoglycoside antibiotics for multidrug-resistant tuberculosis.…
Cancer Drugs Fund needs overhaul, NAO investigation finds The Cancer Drugs Fund is unsustainable in its current form because of overspending and a lack of evidence on the results it yields, according to a report from the National Audit Office.…
Tranexamic acid can cut the need for blood transfusions after surgery A hospital reduced the need for red blood cell transfusions by 40% for patients undergoing a full knee or hip replacement when they routinely gave them tranexamic acid, according to new research.…
Antiretroviral drug Truvada proves its worth in preventing new HIV infections Treating men deemed at high risk of becoming HIV positive with daily antiretroviral medication is extremely effective at preventing new infections, according to new data.…
Survey finds 80% of customers would allow pharmacists to access their GP record Customers using a pharmacy vaccination service are happy for the pharmacist to be allowed access to their GP records, suggests a survey of over 7,000 patients.…
Transplant antifungal drug voriconazole associated with increased skin cancer risk Antifungal drug voriconazole increases the risk of developing skin cancer by 73% in lung transplant patients given the drug to prevent infection with Aspergillus, according to research published in the American Journal of Transplantation.…
FDA approves drug for genetic condition that affects 20 patients worldwide The US Food and Drug Administration has approved uridine triacetate (Xuriden) for the treatment of orotic aciduria – a rare genetic hereditary metabolic disorder that affects just 20 patients worldwide. …
Melanoma drug pembrolizumab gets NICE backing The National Institute for Health and Care Excellence recommends in draft guidance that pembrolizumab (Keytruda) be made available on the NHS for the treatment of some patients with advanced melanoma. …